Remove topics purple-book
article thumbnail

Key Trends in PTAB’s 2021 Orange Book and Biologic Patent Study

LexBlog IP

Patent and Trademark Office Patent Trial and Appeal Board (PTAB) recently released an updated Orange Book patent/biologic patent study on August 11, 2021. The first study covering these topics was released on March 13, 2018, and the second on July 18, 2019. Trends Over Time.

Patent 52
article thumbnail

Does Transformative Matter? No, At Least Where Use Is Commercial

LexBlog IP

And Prince, the Purple One. (Or These were the hot topics in the recently decided Supreme Court case of Andy Warhol Foundation for the Visual Arts, Inc. Prince was unaffected, may he rest in purple peace. Andy Warhol. Or in this case, Orange.) Goldsmith et al. , Money and copyright won by a 7-2 majority. Before us, Ms.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

U.S. Supreme Court Vindicates Photographer But Destabilizes Fair Use — Andy Warhol Foundation v. Goldsmith (Guest Blog Post)

Technology & Marketing Law Blog

A “derivative work” is defined as a “a work based upon one or more preexisting works,” such as the movie version of a book, “or any other form in which a work may be recast, transformed, or adapted.” Vanity Fair selected one of the illustrations to accompany its article, titled “Purple Fame.” Figure 2, slip op. of America v.

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., New FDA Guidance and Information. Conclusion.